Skip to main content

Medical Education Nursing Contact Us

Home
Find a Doctor
Find a Location
Services
Patients and Visitors
MyChart Login

Search

Services

Spartanburg Regional Healthcare System is dedicated to providing patient-centered care to communities we serve. Explore the wide range of services we offer.

Frequently Visited Services

Behavioral Health
Breast Health
Cancer
Emergency
Heart

Hospice
Imaging
Immediate Care
Maternity
Pharmacy

Rehabilitation
Spine
Sports Medicine Institute
Telehealth
Weight Loss

Patients and Visitors

Whether you’re seeking care or visiting a loved one, Spartanburg Regional Healthcare System is here for you. Our compassionate team provides the resources and support you need so you can focus on what is important.

Patients

Advance Directives
Chaplain Services
ER Wait Times
Language Services
Medical Records
MyChart Help and Information
Patient Rights
Planning Discharge
Pre-admission Testing (PAT)
Recognize Your Caregiver
When to Go Where

Visitors

Directions & Maps
Gift Shops
Hotel Information
Visitor Guidelines
Volunteer
Wireless Internet

Financial

Bill Pay
Financial Assistance Program
Insurance Information
Pricing Policies
No Surprises Act

Find a Doctor
Find a Location
Services
Patients and Visitors
MyChart Login
Medical Education
Nursing
Contact Us

Search

Menu

Search

Clinical Research Trials

Search by Name

(-) Gastrointestinal Cancer
Clear all filters

Status

Closed
Complete
Accepting Participants

Disease Site

Oncology
Symptom Management & Cancer Control
Breast Cancer
Thoracic Cancer
Hematologic Cancer
(-) Gastrointestinal Cancer
Genitourinary Cancer
Precision Medicine & Rare Tumors
Cardiology
Cancer Care Delivery Research (CCDR)
Phase 1
Head & Neck Cancer
Cutaneous & Sarcoma Cancer
Gynecologic Cancer
Other
Neurologic Cancer
Nephrology
Neo-Natal
Orthopaedic
Trauma
Wound Healing - Infectious Disease

Study Type

Treatment

Oncology

Oncology

A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers (S1815)
Closed
Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment (EMERALD-2)
Complete
Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast (ES2018-07)
Accepting Participants
Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer, SOLARIS (A021703)
Closed

Gastrointestinal Cancer

A Randomized Phase II Study De-Intensified ChemoRadiation for Early-Stage Anal Squamous Cell Carcinoma (DECREASE) (EA2182)
Accepting Participants
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair, (A021502)
Closed
Cholangiocarcinoma, Nonresectable or Metastatic IDH1 Mutation (AG120-C-005)
Complete
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer (NRG GI004)
Closed
Liver, Non-resectable, (RESIN) Registry
Closed
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer (EA2165)
Closed
Pancreatic Adenocarcinoma, Metastatic (ABI-007-PANC009)
Complete
Pancreatic Adenocarcinoma, Metastatic (NLG2104)
Complete
Pancreatic Cancer, Metastatic (RX-3117)
Complete
The Janus Rectal Cancer Trial: A Randomized Phase II Trial Testing The Efficacy of Triplet Versus Doublet Chemotherapy to Achieve Clinical Complete Response in Patients With Locally Advanced Rectal Cancer (A022104)
Accepting Participants
Phase II/III Study of Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy in Patients with Stage IIA Colon Cancer (COBRA)(NRG GI005)
Closed
Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer (A022004)
Accepting Participants
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (NRG-GI008)
Accepting Participants

Precision Medicine & Rare Tumors

Advanced Cancer, ALT-803 in Combination With PD-1/PD-L1 Checkpoint Inhibitor (QUILT-3.055)
Closed

Cancer Care Delivery Research (CCDR)

Colon or Rectal Cancer, Stage I-III, Financial Burden Assessment (EAQ162CD)
Closed

Symptom Management & Cancer Control

Colorectal Cancer, Cognitive Impairment (URCC 16092)
Complete

Breast Cancer

Solid Tumors, Blood Sample Collection to Evaluate Biomarkers (2018-01)
Closed

Phase 1

Advanced Solid Tumors w/ FGF/FGFR Aberrations (TPU-TAS-120-101)
Closed

ABOUT US

Board of Trustees
Community Health
Diversity and Inclusion
Media Policy
Mission and Vision

News - Discover Health
Policies
Quality
Social Media Guidelines
Spartanburg Regional Healthcare System History
Spartanburg Regional Healthcare System Museum
The Spartanburg Community

RESOURCES

Careers
Employees
Price Transparency
Information for Vendors
Integrity Hotline

Medical Staff Services
Project SEARCH
Safety and Awareness
Sponsorship
Health Library
Transfer Center
Transportation Services
Volunteer

IMPORTANT LINKS

Apella Health Management
Discover Health
Regional HealthPlus
Southeastern Health Partners
Spartanburg Regional Foundation

© 2024 Spartanburg Regional Healthcare System. All Rights Reserved.